
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2 Final//EN">
<HTML>
<HEAD>
<!-- Created by EDGAR Ease Plus (EDGAR Ease+) -->
<!-- Project:        X:\JOBS\04-61738\d04-61738.eep                                   -->
<!-- Control Number: 04-61738                                                         -->
<!-- Rev Number:     1.0                                                              -->
<!-- Client Name:    Osteotech, Inc.                                                  -->
<!-- Project Name:   Form Type: 8-K                                                   -->
<!-- Firm Name:      Osteotech, Inc. (Dorsey & Whitney LLP)                           -->
<TITLE>Osteotech, Inc.</TITLE>
</HEAD>
<BODY>
<div style='width:600;'> <BR>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font SIZE=2>UNITED
    STATES</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font SIZE=2>SECURITIES
    AND EXCHANGE COMMISSION</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font SIZE=2>WASHINGTON,
    DC 20549</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>_____________</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font SIZE=4>FORM
    8-K</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=4>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font SIZE=2>CURRENT
    REPORT</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>Pursuant
    to Section 13 or 15(d) of the</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>Securities
    Exchange act of 1934</font></b></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>Date
    of Report </font><font size=2>(Date of earliest event reported) </font><font size=2>December
    22, 2004</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font SIZE=2>OSTEOTECH,
    INC.</font><u><font size=1>.</font></u></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><font size=2>(Exact
    Name of Registrant as Specified in Charter)</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; text-indent:0.92in;text-align:left;'><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Delaware&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    0-19278&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    13-3357370<br>
    (State or Other Jurisdiction of Incorporation)&nbsp;&nbsp;(Commission File
    Number)&nbsp;&nbsp;&nbsp;(IRS Employer Identification No.)</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; text-indent:0.25in;text-align:left;'><font size=2>51
    James Way, Eatontown, New Jersey&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    07724<br>
    </font><font size="1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font><font size=2>(Address
    of Principal Executive Offices)&nbsp;</font><font size=2> </font><font size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    (Zip Code)</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <table border="0" cellspacing=0 cellpadding=0 width="585" style=' border-collapse:collapse'>
    <tr>
      <td width="562" valign=top >
        <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>Registrant&#146;s
          telephone number, including area code (732) 542-2800 </font></p>
      </td>
      <td width="23" valign=top >
        <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'></p>
      </td>
    </tr>
  </table>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><b><font size=2>________________________________________________________________________________</font></b></p>
  <table border="0" cellspacing=0 cellpadding=0 width="350" style='border-collapse: collapse; margin-left: 105.0pt'>
    <tr>
      <td width="500" valign=top nowrap>
        <p><font size=2>(Former Name or Former Address, if Changed Since Last
          Report)</font></p>
      </td>
    </tr>
  </table>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; text-indent:0.38in;text-align:left;'><font size=2>Check
    the appropriate box below if the Form 8-K filing is intended to simultaneously
    satisfy the filing obligation of the registrant under any of the following
    provisions (see General Instruction A.2. below): </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:0.12in;text-align:left;'><font size=2>|_|&nbsp;&nbsp;&nbsp;
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425) </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:0.12in;text-align:left;'><font size="2">|_|&nbsp;&nbsp;&nbsp;
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12) </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:0.12in;text-align:left;'><font size=2>|_|&nbsp;&nbsp;&nbsp;
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b)) </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:0.12in;text-align:left;'><font size=2>|_|&nbsp;&nbsp;&nbsp;
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c)) </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <HR noshade align="center" width="100%" size="5">
  <p style='page-break-before:always'></p>
  <pAGE>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><u><font size=2>Item
    1.01 Entry into a Material Definitive Agreement</font></u></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>Osteotech,
    Inc. (&#147;Osteotech&#148; or the &#147;Company&#148;) announced in November
    2004 that it had been informed by the American Red Cross Transplantation Services
    (&#147;ARC&#148;) and the Musculoskeletal Transplant Foundation (&#147;MTF&#148;)
    that ARC and MTF have entered into an agreement for MTF to acquire the assets
    related to ARC&#146;s allograft tissue banking operations and anticipate closing
    this asset acquisition sometime in January 2005. Also announced was that Osteotech
    and MTF had reached an agreement in principle for a second processing agreement. </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>On
    December 22, 2004, Osteotech and MTF have signed a definitive agreement for
    a second processing agreement, which will be effective upon the closing of
    the ARC/MTF asset acquisition agreement. Pursuant to the second MTF processing
    agreement, MTF will provide Osteotech with a certain amount of standard donors
    for processing that is equivalent to the amount of standard donors required
    to be delivered by ARC to Osteotech under the existing processing agreement
    with ARC. All Grafton&#174; DBM and Grafton&#174; Bio-Implants processed from
    donors delivered to Osteotech under the Second MTF Processing Agreement will
    be distributed to hospital end-users by Osteotech under the Osteotech label.
    Base tissue products processed under the Second MTF Processing Agreement will
    be distributed by MTF. The second MTF processing agreement, which has an initial
    term that expires in December 2006, can be extended for two additional one-year
    periods in the event Osteotech is able to meet certain processing yield requirements.
    The terms and conditions of the original Osteotech and MTF processing agreement
    entered into in June 2002 and continuing through December 2008 are not impacted
    by the second MTF processing agreement or the ARC/MTF asset acquisition agreement.
    Separately and as a result of the pending transaction between ARC and MTF,
    Osteotech is holding discussions with ARC to negotiate the termination of
    its processing agreement with ARC. </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>In
    addition, Osteotech, ARC and MTF have negotiated and signed several arrangements
    establishing protocols and procedures to ensure a consistent number and flow
    of donors delivered to Osteotech during the period prior to the closing of
    the ARC/MTF asset acquisition transaction. Under these transition arrangements,
    MTF will deliver to Osteotech the types and quantities of donors required
    to be delivered by ARC under the existing ARC processing agreement, although
    such donors will be processed principally in accordance with the terms of
    the second MTF processing agreement. This arrangement will end upon the closing
    of the ARC/MTF asset acquisition transaction and the second processing agreement
    between Osteotech and MTF becoming effective. </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>Certain
    statements made throughout this current report that are not historical facts
    contain forward-looking statements (as such are defined in the Private Securities
    Litigation Reform Act of 1995) regarding the Company&#146;s future plans,
    objectives and expected performance. Any such forward-looking statements are
    based on assumptions that the Company believes are reasonable, but are subject
    to a wide range of risks and uncertainties and, therefore, there can be no
    assurance that actual results may not differ materially from those expressed
    or implied by such forward-looking statements. Factors that could cause actual
    results to differ materially include, but are not limited to, the failure
    of MTF&#146;s acquisition of ARC&#146;s allograft tissue banking assets to
    close and the resulting failure of Osteotech&#146;s second processing agreement
    with MTF to become effective, Osteotech&#146;s inability to satisfactorily
    resolve issues relating the termination of </font></p>
  <p style='margin-top: 0pt; margin-bottom: 0pt' align="center"><font size=2><br>
    2&nbsp;</font></p>
  <br>
  <HR noshade align="center" width="100%" size="5">
  <pAGE>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>the
    ARC processing agreement, differences in anticipated and actual product and
    service introduction dates, the ultimate success of those products in the
    market place, the continued acceptance and growth of current products and
    services, the impact of competitive products and services, the availability
    of sufficient quantities of suitable donated tissue and the success of cost
    control and margin improvement efforts which factors are detailed from time
    to time in the Company&#146;s periodic reports (including the Annual Report
    on Form 10-K for the year ended December 31, 2003 and the Form 10-Q for each
    of the first three quarters of 2004) filed with the Securities and Exchange
    Commission. All information in this current report is as of December 28, 2004
    and the Company undertakes no duty to update this information. </font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><u><font size=2>Item
    9.01 Financial Statements and Exhibits</font></u></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>Exhibit
    List</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>Exhibit
    99.1 Press Release dated December 28, 2004</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'> </p>
  <p style='margin-top: 0pt; margin-bottom: 0pt' align="center"><font size=2>3&nbsp;</font></p>
  <br>
  <HR noshade align="center" width="100%" size="5">
  <pAGE>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:center;'><u><font SIZE=2>SIGNATURES</font></u></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; text-indent:0.36in;text-align:left;'><font size=2>Pursuant
    to the requirements of the Securities Exchange Act of 1934, the Registrant
    has duly caused this report to be signed on its behalf by the undersigned
    hereunto duly authorized.</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>Dated:
    December 28, 2004</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt;text-align:left;'><font size=2>&nbsp;</font></p>
  <table border="0" cellspacing=0 cellpadding=0 width="266" style='border-collapse: collapse; margin-left: 266.0pt'>
    <tr>
      <td  colspan="4" valign=top height="17" width="262" align="center" >
        <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font SIZE=2>&nbsp;&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          OSTEOTECH, INC.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          </u></font></p>
      </td>
    </tr>
    <tr >
      <td  width="260" height="17" colspan="4">
        <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=1>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          &nbsp;</font><font size=2>&nbsp;(Registrant)</font><font size=1>&nbsp;</font>
      </td>
    </tr>
    <tr>
      <td width="35" height="21" ></td>
      <td width="77" height="21" ></td>
      <td width="75" height="21" ></td>
      <td width="71" height="21" ></td>
    </tr>
  </table>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.75in;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.75in;text-align:left;'><font size=2>&nbsp;</font></p>
  <table border="0" cellspacing=0 cellpadding=0 width="282" style=' margin-left:3.75in;border-collapse:collapse'>
    <tr>
      <td width="258" valign=top >
        <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2>By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/
        Michael J. Jeffries&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font></p>
      </td>
      <td width="24" valign=top >
        <p style='margin-left:0pt;text-indent:0pt;text-align:left;margin-top:0pt;margin-bottom:0pt'><font size=2></font></p>
      </td>
    </tr>
  </table>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.94in;text-align:left;'><font size=2>Michael
    J. Jeffries</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.94in;text-align:left;'><font size=2>Executive
    Vice President,</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.94in;text-align:left;'><font size=2>Chief
    Financial Officer</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.94in;text-align:left;'><font size=2>(Principal
    Financial Officer</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.94in;text-align:left;'><font size=2>and
    Principal Accounting Officer)</font></p>
  <p style=' margin-bottom:0pt; margin-top:0pt; margin-left:3.94in;text-align:left;'><font size=2>&nbsp;</font></p>
  <p style='margin-top: 0pt; margin-bottom: 0pt' align="center"><font size=2>&nbsp;4</font></p>
  <br>
  <HR noshade align="center" width="100%" size="5">


</div>
</BODY>
</HTML>








